Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
Subscribe To Our Newsletter & Stay Updated